Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruining Zhang

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
JACC. Cardiovascular Interventions|March 26, 2026
Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions: The REC-CAGEFREE I TrialBin Zhu, Fei Li, Jianzheng Liu, et al.
BMJ (Clinical Research Ed.)|March 31, 2025
Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trialChao Gao, Bin Zhu, Fan Ouyang, et al.
Journal of the American College of Cardiology|November 6, 2025
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I TrialLing Tao, Xingqiang He, Guidong Shen, et al.
Lancet (London, England)|September 5, 2024
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trialChao Gao, Xingqiang He, Fan Ouyang, et al.
Journal of Translational Medicine|April 16, 2009
GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairmentPu Dai, Fei Yu, Bing Han, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
JACC. Cardiovascular Interventions|March 26, 2026
Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions: The REC-CAGEFREE I TrialBin Zhu, Fei Li, Jianzheng Liu, et al.
BMJ (Clinical Research Ed.)|March 31, 2025
Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trialChao Gao, Bin Zhu, Fan Ouyang, et al.
Journal of the American College of Cardiology|November 6, 2025
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I TrialLing Tao, Xingqiang He, Guidong Shen, et al.
Lancet (London, England)|September 5, 2024
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trialChao Gao, Xingqiang He, Fan Ouyang, et al.
Journal of Translational Medicine|April 16, 2009
GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairmentPu Dai, Fei Yu, Bing Han, et al.
Pageof 8